Clinical trials
Completed Obesity, Morbid trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
514 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 9 |
| 2006 | 12 |
| 2007 | 21 |
| 2008 | 19 |
| 2009 | 28 |
| 2010 | 17 |
| 2011 | 31 |
| 2012 | 32 |
| 2013 | 21 |
| 2014 | 31 |
| 2015 | 22 |
| 2016 | 35 |
| 2017 | 34 |
| 2018 | 43 |
| 2019 | 30 |
| 2020 | 25 |
| 2021 | 25 |
| 2022 | 27 |
| 2023 | 17 |
| 2024 | 7 |
| 2025 | 13 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 514 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Minia University | 15 |
| Mansoura University | 10 |
| Inonu University | 9 |
| Norwegian University of Science and Technology | 9 |
| Hvidovre University Hospital | 7 |
| Rijnstate Hospital | 7 |
| University of Foggia | 7 |
| Assistance Publique - Hôpitaux de Paris | 6 |
| Ethicon Endo-Surgery | 5 |
| Johns Hopkins University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity, Morbid | 514 |
| Obesity | 145 |
| Weight Loss | 41 |
| Diabetes Mellitus, Type 2 | 21 |
| Postoperative Pain | 15 |
| Diabetes Mellitus | 14 |
| Insulin Resistance | 13 |
| Metabolic Syndrome | 12 |
| Non-alcoholic Fatty Liver Disease | 12 |
| Gastroesophageal Reflux | 9 |
Trials
Showing 76 to 100 of 514. Each trial links to its page on Pharma Observatory.
414 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.